Study of the toxicity of a new lipid complex formulation of amphotericin B
- PMID: 14657087
- DOI: 10.1093/jac/dkh025
Study of the toxicity of a new lipid complex formulation of amphotericin B
Abstract
Objectives: The aim of this study was to evaluate the toxicity of a new lipid complex formulation of amphotericin B (LC-AmB) produced by a simple process.
Methods: Toxicity was evaluated after daily administration for 21 consecutive days in female CD1 mice. Doses of LC-AmB up to 20 mg/kg were used, and compared with Fungizone at 0.5 mg/kg and Abelcet at 10 mg/kg. Acute toxicity after a single bolus injection was also determined, as well as the haemolytic activity and toxicity to mouse macrophages in vitro.
Results: LC-AmB reduced both the haemolytic activity of amphotericin B and its toxicity towards mouse peritoneal macrophages. Its acute toxicity (LD50 > 200 mg/kg in CD1 mice) was similar to that in the literature for the least toxic lipid formulations of amphotericin B. The relative liver weight increased slightly in mice treated daily with a dose of 20 mg/kg LC-AmB, as did the kidney weight in this group and the group treated with Fungizone. There was also a dose-dependent decrease in the haematocrit with all formulations. All treatments caused significant increases in transaminase levels. Total hepatic CYP 450 was slightly but not significantly increased in the groups treated with 20 mg/kg LC-AmB, Abelcet and Fungizone. However, expression of some isoforms of CYP 450 was reduced, the most marked being the hepatic CYP 3A1 after treatment with 20 mg/kg LC-AmB, Abelcet and Fungizone. The effects on hepatic function are probably related to accumulation in organs rich in phagocytic cells.
Conclusion: LC-AmB did not induce any new toxicity compared with Abelcet and Fungizone.
Similar articles
-
Safety evaluation of ABELCET, an amphotericin B lipid complex (ABLC): toxicity studies in rats.Int J Toxicol. 2006 Jul-Aug;25(4):285-94. doi: 10.1080/10915810600746106. Int J Toxicol. 2006. PMID: 16815817
-
Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments.J Antimicrob Chemother. 2005 May;55(5):727-34. doi: 10.1093/jac/dki064. Epub 2005 Mar 10. J Antimicrob Chemother. 2005. PMID: 15761070
-
Comparative immunotoxicity evaluation of amphotericin B and ABELCET, an amphotericin B lipid complex (ABLC).Int J Toxicol. 2006 Nov-Dec;25(6):487-92. doi: 10.1080/10915810600961242. Int J Toxicol. 2006. PMID: 17132607
-
The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.Oncol Nurs Forum. 1998 Jan-Feb;25(1):35-48. Oncol Nurs Forum. 1998. PMID: 9460772 Review.
-
Development of liposomal amphotericin B formulation.J Microencapsul. 1998 Mar-Apr;15(2):137-51. doi: 10.3109/02652049809006844. J Microencapsul. 1998. PMID: 9532520 Review.
Cited by
-
Branched amphotericin functional poly(N-isopropyl acrylamide): an antifungal polymer.R Soc Open Sci. 2021 Jan 13;8(1):201655. doi: 10.1098/rsos.201655. eCollection 2021 Jan. R Soc Open Sci. 2021. PMID: 33614095 Free PMC article.
-
Building Blocks to Design Liposomal Delivery Systems.Int J Mol Sci. 2020 Dec 15;21(24):9559. doi: 10.3390/ijms21249559. Int J Mol Sci. 2020. PMID: 33334048 Free PMC article. Review.
-
Biodistribution and In Vivo Antileishmanial Activity of 1,2-Distigmasterylhemisuccinoyl-sn-Glycero-3-Phosphocholine Liposome-Intercalated Amphotericin B.Antimicrob Agents Chemother. 2017 Aug 24;61(9):e02525-16. doi: 10.1128/AAC.02525-16. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28630182 Free PMC article.
-
Properties of An Oral Nanoformulation of A Molecularly Dispersed Amphotericin B Comprising A Composite Matrix of Theobroma Oil and Bee'S Wax.Nanomaterials (Basel). 2014 Dec 19;4(4):905-916. doi: 10.3390/nano4040905. Nanomaterials (Basel). 2014. PMID: 28344257 Free PMC article.
-
Anti-fungal activity of Ctn[15-34], the C-terminal peptide fragment of crotalicidin, a rattlesnake venom gland cathelicidin.J Antibiot (Tokyo). 2017 Mar;70(3):231-237. doi: 10.1038/ja.2016.135. Epub 2016 Nov 23. J Antibiot (Tokyo). 2017. PMID: 27876749
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources